In situ self-assembly of molybdenum carbide and iron carbide heterostructures on N-doped carbon for an efficient oxygen reduction reaction.

Identifying highly stable, cost-effective, platinum-free, and efficient electrocatalysts for the oxygen reduction reaction (ORR) remains a formidable challenge. The ORR is important for advancing fuel cell and zinc-air battery (ZAB) technologies towards cost-efficiency and environmental sustainability. This work presents the utilization of economically viable materials through a straightforward synthesis process, exhibiting the development of efficient Mo2C/Fe3C-NC catalysts ingeniously derived from phosphomolybdic acid (PMA) and iron phthalocyanine (FePc). The results demonstrate that the optimized Mo2C/Fe3C-NC3 catalysts exhibit remarkable electrochemical performance, evidenced by an impressive onset potential of ∼1.0 V versus RHE, a half-wave potential of 0.89 V, and a superior current density of about 6.2 mA cm-2. As for their performance in ZABs, the optimized catalysts reach a peak power density of 142 mW cm-2 at a current density of 200 mA cm-2. This synergy, coupled with the uniform distribution of Mo2C and Fe3C nanoparticles, greatly enhances the active catalytic sites and promotes electrolyte diffusion. Our approach diverges from traditional methods by employing an in situ self-assembled heterostructure of Mo2C/Fe3C on nitrogen-doped carbon tubes, avoiding the conventional high-temperature hydrogen gas reduction process. Beyond serving as feasible alternatives to commercially available Pt/C catalysts, these materials hold promise for large-scale production owing to their affordability and the simplicity of the synthesis technique. Such a breakthrough paves the way towards the realization of sustainable energy technologies and lays the groundwork for further exploration into amplifying the scalability and efficiency of ORR catalysts.

3D Hierarchical MOF-Derived Defect-Rich NiFe Spinel Ferrite as a Highly Efficient Electrocatalyst for Oxygen Redox Reactions in Zinc-Air Batteries.

The strategy of defect engineering is increasingly recognized for its pivotal role in modulating the electronic structure, thereby significantly improving the electrocatalytic performance of materials. In this study, we present defect-enriched nickel and iron oxides as highly active and cost-effective electrocatalysts, denoted as Ni0.6Fe2.4O4@NC, derived from NiFe-based metal-organic frameworks (MOFs) for oxygen reduction reactions (ORR) and oxygen evolution reactions (OER). XANES and EXAFS confirm that the crystals have a distorted structure and metal vacancies. The cation defect-rich Ni0.6Fe2.4O4@NC electrocatalyst exhibits exceptional ORR and OER activities (ΔE = 0.68 V). Mechanistic pathways of electrochemical reactions are studied by DFT calculations. Furthermore, a rechargeable zinc-air battery (RZAB) using the Ni0.6Fe2.4O4@NC catalyst demonstrates a peak power density of 187 mW cm-2 and remarkable long-term cycling stability. The flexible solid-state ZAB using the Ni0.6Fe2.4O4@NC catalyst exhibits a power density of 66 mW cm-2. The proposed structural design strategy allows for the rational design of electronic delocalization of cation defect-rich NiFe spinel ferrite attached to ultrathin N-doped graphitic carbon sheets in order to enhance active site availability and facilitate mass and electron transport.

Strategic Design and Insights into Lanthanum and Strontium Perovskite Oxides for Oxygen Reduction and Oxygen Evolution Reactions.

Perovskite oxides exhibit bifunctional activity for both oxygen reduction (ORR) and oxygen evolution reactions (OER), making them prime candidates for energy conversion in applications like fuel cells and metal-air batteries. Their intrinsic catalytic prowess, combined with low-cost, abundance, and diversity, positions them as compelling alternatives to noble metal and metal oxides catalysts. This review encapsulates the nuances of perovskite oxide structures and synthesis techniques, providing insight into pivotal active sites that underscore their bifunctional behavior. The focus centers on the breakthroughs surrounding lanthanum (La) and strontium (Sr)-based perovskite oxides, specifically their roles in zinc-air batteries (ZABs). An introduction to the mechanisms of ORR and OER is provided. Moreover, the light is shed on strategies and determinants central to optimizing the bifunctional performance of La and Sr-based perovskite oxides.

Correction: Tailoring the MOF structure via ligand optimization afforded a dandelion flower like CoS/Co-Nx/CoNi/NiS catalyst to enhance the ORR/OER in zinc-air batteries.

Correction for 'Tailoring the MOF structure via ligand optimization afforded a dandelion flower like CoS/Co-Nx/CoNi/NiS catalyst to enhance the ORR/OER in zinc-air batteries' by Mohan Gopalakrishnan et al., Nanoscale, 2022, 14, 17908-17920, https://doi.org/10.1039/D2NR04933C.

Tailoring the MOF structure via ligand optimization afforded a dandelion flower like CoS/Co-Nx/CoNi/NiS catalyst to enhance the ORR/OER in zinc-air batteries.

Due to their affordability and good catalytic activity for oxygen reactions, MOF-derived carbon composites containing metal alloys have piqued interest. However, during synthesis, MOFs have the disadvantage of causing significant carbon evaporation, resulting in a reduction of active sites and durability. This study proposes tailoring the molecular structure of MOFs by optimizing bipyridine and flexible 4-aminodiacetic terephthalic acid ligands, which have numerous coordination modes and framework structures, resulting in fascinating architectures. MOF frameworks having optimized N and O units are coordinated with Co and Ni ions to provide MOF precursors that are annealed at 700 °C in argon. The MOF-derived Co9S8/Co-Nx/CoNi/Ni3S2@CNS-4 catalyst exhibits excellent catalytic activity, revealing an ORR half-wave potential of 0.86 V and an overpotential (OER) of 196 mV at 10 mA cm-2, a potential gap of 0.72 V and a Tafel slope of 79 mV dec-1. The proposed strategy allows for the rational design of N-coordinated Co and CoNi alloys attached to ultrathin N, S co-doped graphitic carbon sheets to enhance bifunctional activity and sufficient active sites. Consequently, the zinc-air battery using the synthesized catalyst shows a high peak power density of 206.9 mW cm-2 (Pt/C + RuO2 116.1 mW cm-2), a small polarization voltage of 0.96 V after 370 h at 10 mA cm-2, and an outstanding durability of over 2400 cycles (400 h). The key contributions to the superior performance are the synergetic effects of the CoNi alloys plus the N,S-incorporated carbon skeleton, due to the small charge transfer resistances and enhanced active sites of CoNi, metal-S, and pyridinic N.

Detection methods for sub-nanogram level of emerging pollutants - Per and polyfluoroalkyl substances.

Per- and polyfluoroalkyl substances (PFAS) are organofluorine compounds has been manufactured for more than five decades and used in different purposes. Among persistent organic pollutants, PFAS are toxic, bioaccumulative in humans, wildlife, and global environment. As per environmental protection agency (EPA) guidelines, the perfluorooctanoate and perfluorooctane sulfonate permissible limit was 0.07 ng/L in drinking water. When the concentration exceeds the acceptable limit, it has negative consequences for humans. In such a case, PFAS monitoring is critical, and a quick detection technique are highly needed. Health departments and regulatory agencies have interests in monitoring of PFAS presences and exposures. For the detection of PFAS, numerous highly precise and sensitive chromatographic methods are available. However, the drawbacks of analytical techniques include timely sample preparations and the lack of on-site applicability. As a result, there is an increasing demand for simple sensor systems for monitoring of PFAS in real field samples. In this review, we first describe the sample pre-treatment and analytical techniques for the detection of PFAS. Second, we broadly discussed available sensor system for the quantification of PFAS in different filed samples. Finally, future trends in PFASs sensor are also presented.

Functionality study of santalin as tyrosinase inhibitor: A potential depigmentation agent.

Excessive melanin production leads to hyperpigmentation disorders which results in distressing aesthetic values. Though there are some synthetic depigmentation agents available it has been reported to possess cytotoxic and mutagenic effects. Hence there is a need for the development of safe and non toxic natural tyrosinase inhibitors. Here we report the role of santalin, the chief constituent of Pterocarpus santalinus in inhibition of tyrosinase and melanin synthesis. Santalin inhibited tyrosinase activity dose dependently. Inhibitory kinetic studies revealed mixed type of inhibition with reversible mechanism. Santalin was found to interact with the fluorophore amino acid residue of tyrosinase. Analysis of circular dichroism spectra showed the binding of santalin to tyrosinase which induced the loss of secondary helical structure. Molecular docking result suggested that santalin interact with the catalytic core of tyrosinase through strong hydrogen and hydrophobic bonding. The results of in vitro studies showed santalin inhibited melanogenesis through down regulation of MITF, tyrosinase, TRP-1 and TRP-2 without any cytotoxic effects towards B16F0 melanoma cells. Therefore, our results suggested that santalin possesses anti-tyrosinase activity, which could be utilized as a safe depigmentation agent in the cosmetic field for the treatment of hyperpigmentation disorder.

Inhibitory effect of apocarotenoids on the activity of tyrosinase: Multi-spectroscopic and docking studies.

In this present study, the inhibitory mechanism of three selected apocarotenoids (bixin, norbixin and crocin) on the diphenolase activity of tyrosinase has been investigated. The preliminary screening results indicated that apocarotenoids inhibited tyrosinase activity in a dose-dependent manner. Kinetic analysis revealed that apocarotenoids reversibly inhibited tyrosinase activity. Analysis of fluorescence spectra showed that apocarotenoids quenched the intrinsic fluorescence intensity of the tyrosinase. Further, molecular docking results implied that apocarotenoids were allosterically bound to tyrosinase through hydrophobic interactions. The results of the in vitro studies suggested that higher concentrations of bixin and norbixin inhibited tyrosinase activity in B16F0 melanoma cells. Our results suggested that apocarotenoids could form the basis for the design of novel tyrosinase inhibitors.

Inhibitory effect of brazilein on tyrosinase and melanin synthesis: Kinetics and in silico approach.

In our present study, the inhibitory effect of brazilein from Caesalpinia sappan on tyrosinase activity was investigated through multi-spectroscopic and molecular docking techniques. The result has shown that brazilein reversibly inhibited tyrosinase in a mixed type manner. The interaction of brazilein with the amino acid residues of tyrosinase has been validated through fluorescence quenching studies. Copper interaction studies suggested that brazilein could bind with copper ions of the enzyme. Circular dichroism analysis confirmed that brazilein induced secondary structural changes in tyrosinase. Docking studies further authenticate that brazilein forms hydrophobic and hydrogen bonding with the active site residues of tyrosinase. Moreover, in vitro studies confirmed that the inhibitory mechanism of cellular tyrosinase and melanin synthesis by brazilein in B16F0 melanoma cells. These results suggested that brazilein act as a potential tyrosinase inhibitor and it would contribute as a of novel tyrosinase inhibitor in food, cosmetic and pharmaceutical industry.

Monomeric mixed cadmium-2,2'-dipyridylamine complex derived from ferrocenecarboxylic acid: Structural, electrochemical and biological studies.

A mixed Cd(II) complex {[Cd(FcCOO)2(dpyam)(H2O)][Cd(dpyam)2 (H2O)2]·(ClO4)2·CH3OH} (1) (where FcCOO=ferrocenecarboxylic acid and dpyam=2,2'-dipyridylamine), has been synthesized and characterized by FT-IR, (1)H &(13)C NMR, UV-Vis spectroscopy and elemental analysis. The molecular structure of compound 1 has been determined by the single crystal X-ray diffraction technique, which consists of mixed two different cadmium(II) complexes and two uncoordinated perchlorate ions. The crystal packing shows that the compound 1 self-assembled by intermolecular hydrogen bonding via pyridyl N-H⋯O and coordinated water O⋯H-O-H⋯O, to afford the molecule 2D supramolecular network. Compound 1 exhibits high-energy intraligand (π-π(∗)) fluorescence emission. In electrochemical studies of compound 1 shows negative potential compared with ferrocenecarboxylic acid due to formation of coordination complex with Cd ions. The antibacterial study against the distinct bacterial strains show compound 1 has significant activity.

Lack of mutation in p53 and H-ras genes in phenytoin induced gingival overgrowth suggests its non cancerous nature.

BACKGROUND: There have been case reports of oral squamous cell carcinoma arising from gingival overgrowth induced by phenytoin--an antiepileptic drug. However, a detailed analysis for the presence of mutations in p53 and ras genes, which are the two most frequently mutated genes in cancers, in phenytoin induced gingival overgrowth tissues has hitherto not been performed. METHODS: Cellular DNA isolated from twenty gingival overgrowth tissues collected from patients undergoing phenytoin therapy were amplified using primers for p53 (exons 5-8) and H-ras (exons 1-2) genes. The PCR amplicons were then gel purified and subjected to direct sequencing analysis to screen for mutations. RESULTS: Direct sequencing of twenty samples of phenytoin induced gingival growth did not identify mutations in any of the exons of p53 and H-ras genes that were analyzed. CONCLUSION: Our result indicates that mutational alteration of p53 and H-ras genes is infrequent in phenytoin induced gingival growth, which thus suggests a non malignant nature of this pathology. The findings in the present study are clinically significant as a large number of epileptic patients are treated with phenytoin.

Common docking domain mutation E322K of the ERK2 gene is infrequent in oral squamous cell carcinomas.

BACKGROUND: Mutations in the MAPK (Mitogen Activated Protein Kinase) signaling pathway - EGFR/Ras/ RAF/MEK have been associated with the development of several carcinomas. ERK2, a downstream target of the MAPK pathway and a founding member of the MAPK family is activated by cellular signals emanating at the cell membrane. Activated ERK2 translocates into the nucleus to transactivate genes that promote cell proliferation. MKP - a dual specific phosphatase - interacts with activated ERK2 via the common docking (CD) domain of the later to inactivate (dephosphorylate) and effectively terminate further cell proliferation. A constitutively active form of ERK2 carrying a single point mutation (E322K) in its CD domain, was earlier reported by our laboratory. In the present study, we investigated the prevalence of this CD domain E322K mutation in 88 well differentiated OSCC tissue samples. MATERIALS AND METHOD: Genomic DNA specimens isolated from 88 oral squamous cell carcinoma tissue samples were amplified with primers flanking the CD domain of the ERK2 gene. Subsequently, PCR amplicons were gel purified and subjected to direct sequencing to screen for mutations. RESULTS: Direct sequencing of eighty eight OSCC samples identified an E322K CD domain mutation in only one (1.1%) OSCC sample. CONCLUSIONS: Our result indicates that mutation in the CD domain of ERK2 is rare in OSCC patients, which suggests the role of genetic alterations in other mitogenic genes in the development of carcinoma in the rest of the patients. Nevertheless, the finding is clinically significant, as the relatively rare prevalence of the E322K mutation in OSCC suggests that ERK2, being a common end point signal in the multi-hierarchical mitogen activated signaling pathway may be explored as a viable drug target in the treatment of OSCC.

Current pulse: can a production system reduce medical errors in health care?

One of the reasons for rising health care costs is medical errors, a majority of which result from faulty systems and processes. Health care in the past has used process-based initiatives such as Total Quality Management, Continuous Quality Improvement, and Six Sigma to reduce errors. These initiatives to redesign health care, reduce errors, and improve overall efficiency and customer satisfaction have had moderate success. Current trend is to apply the successful Toyota Production System (TPS) to health care since its organizing principles have led to tremendous improvement in productivity and quality for Toyota and other businesses that have adapted them. This article presents insights on the effectiveness of TPS principles in health care and the challenges that lie ahead in successfully integrating this approach with other quality initiatives.